top of page

Latest News

May 7, 2025

Fighting Cancer, Easing Pain... Dr. Lorin Johnson, CSO, Glycyx Therapeutics

https://www.biotechnation.com/episodes/fighting-cancer-easing-pain-dr-lorin-johnson-cso-glycyx-therapeutics

Fighting Cancer, Easing Pain... Dr. Lorin Johnson, CSO, Glycyx Therapeutics
Read More

Dec 4, 2024

Groundbreaking Research from UPMC Highlights Opioids’ Suppressive Impact on Immune Checkpoint Inhibitors and the Potential of Axelopran, an Opioid Antagonist to Reverse It

https://www.biospace.com/press-releases/groundbreaking-research-from-upmc-highlights-opioids-suppressive-impact-on-immune-checkpoint-inhibitors-and-the-potential-of-axelopran-an-opioid-antagonist-to-reverse-it

Groundbreaking Research from UPMC Highlights Opioids’ Suppressive Impact on Immune Checkpoint Inhibitors and the Potential of Axelopran, an Opioid Antagonist to Reverse It
Read More

©2025 by Glycyx Therapeutics

bottom of page